Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Pietro Desimone
 -- 1387 2023-05-25 09:29:39 |
2 layout
Camila Xu
 Meta information modification 1387 2023-05-25 09:49:32 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Rebecchi, M.; Fanisio, F.; Rizzi, F.; Politano, A.; De Ruvo, E.; Crescenzi, C.; Panattoni, G.; Squeglia, M.; Martino, A.; Sasso, S.; et al. Autonomic Nervous System Role in Coumel’s Triangle. Encyclopedia. Available online: https://encyclopedia.pub/entry/44819 (accessed on 17 November 2024).
Rebecchi M, Fanisio F, Rizzi F, Politano A, De Ruvo E, Crescenzi C, et al. Autonomic Nervous System Role in Coumel’s Triangle. Encyclopedia. Available at: https://encyclopedia.pub/entry/44819. Accessed November 17, 2024.
Rebecchi, Marco, Francesca Fanisio, Fabio Rizzi, Alessandro Politano, Ermenegildo De Ruvo, Cinzia Crescenzi, Germana Panattoni, Marianna Squeglia, Annamaria Martino, Stefano Sasso, et al. "Autonomic Nervous System Role in Coumel’s Triangle" Encyclopedia, https://encyclopedia.pub/entry/44819 (accessed November 17, 2024).
Rebecchi, M., Fanisio, F., Rizzi, F., Politano, A., De Ruvo, E., Crescenzi, C., Panattoni, G., Squeglia, M., Martino, A., Sasso, S., Golia, P., Pugliese, G., Del Gigante, S., Giamundo, D., Desimone, P., Grieco, D., De Luca, L., Giordano, I., Barillà, F., ...Iellamo, F. (2023, May 25). Autonomic Nervous System Role in Coumel’s Triangle. In Encyclopedia. https://encyclopedia.pub/entry/44819
Rebecchi, Marco, et al. "Autonomic Nervous System Role in Coumel’s Triangle." Encyclopedia. Web. 25 May, 2023.
Autonomic Nervous System Role in Coumel’s Triangle
Edit
This entry is adapted from the peer-reviewed paper 10.3390/life13051139

Arrhythmogenic substrate, modulating factors, and triggering factors (the so-called Coumel’s triangle concept) play a primary role in atrial fibrillation (AF) pathophysiology. Several years have elapsed since the concept of the relevance of autonomic nervous system (ANS) influences on atrial cells’ electrophysiological characteristics was advanced.

atrial fibrillation autonomic nervous system sympathetic parasympathetic

1. Introduction

Arrhythmogenic substrate, modulating factors, and triggering factors (the so-called Coumel’s triangle concept) play a primary role in atrial fibrillation (AF) pathophysiology. Several years have elapsed since Coumel et al. [1] advanced the concept of the relevance of autonomic nervous system (ANS) influences on atrial cells’ electrophysiological characteristics. The ANS is not only associated with cardiac rhythm regulation but also exerts an important role in the triggering and maintenance of atrial fibrillation. The heart is richly innervated by the autonomic system that can be located either inside the heart (intrinsic ANS) or in brainstem and cardiac preganglionic fibers (extrinsic ANS). Both intrinsic and extrinsic autonomic nervous system divisions are fundamental for cardiac function and arrhythmogenesis [2][3][4].

2. The Biomolecular Explanation of the Autonomic Nervous System Role in Coumel’s Triangle

Each of the myocardial sleeves of the pulmonary veins (PVs) is richly innervated by four of the left atrial GP [5]. These four GPs are localized in areas of fractioned atrial potentials, as widely described in the literature [6]. Po et al. demonstrated that the injection of acetylcholine into the GP can induce focal firing coming from adjacent pulmonary veins [7]. Moreover, in animal models of PV preparations with a surrounding left atrial myocardial tissue, local autonomic stimulation induces early afterdepolarizations (EADs) and bursts of triggered firing from the PVs [8]. This triggered activation was similar to the pattern recorded from the PVs in patients with paroxysmal AF [6]. It must be underlined that in autonomic nerve structures, there is a frequent co-localization of sympathetic and parasympathetic fibers making a complete selective radiofrequency catheter ablation extremely difficult. The spatial and functional interplay between sympathetic and parasympathetic fibers plays a relevant role in starting and maintaining the AF burden [9]; for example, sympathetic stimulation would promote cholinergic-mediated AF initiation [10].

2.1. Cardiac Autonomic Neurotransmission: Adrenergic and Cholinergic Molecular Pathways

The effect of the autonomic nervous system on cardiomyocytes is mainly related to changes in ion channel functioning, leading to action potential length, conductive forces, and conduction velocity modifications (Figure 1). The extremely complex mechanism of neurotransmitter production, release, and reuptake is highly regulated [11].
Life 13 01139 g001
Figure 1. Autonomic nervous system and atrial fibrillation. Biomolecular mechanisms and the influence of the ANS on triggers and atrial reentry mechanisms. See text for explanation.
Norepinephrine is the principal neurotransmitter of the sympathetic autonomic system: it is synthesized in neural cell bodies and stored in vesicles adjacent to nerve varicosities close to adrenergic receptors where they are released through a Ca2+-dependent process.
Norepinephrine binds to a variety of adrenergic receptors in cardiomyocytes and the precise, extremely complex mechanisms have been broadly described [12].
The β-adrenergic receptor is a member of the family of 7-transmembrane domain G protein-coupled receptors. It comprises three subtypes, β1–3, of which β1 receptors are the most involved in the pathogenesis of atrial arrhythmias. Norepinephrine’s link to the β-receptor leads to a free Gαs subunit that activates adenylate cyclase and converts ATP to cAMP. cAMP is the primary β-adrenergic second messenger; it activates protein kinase A (PKA) that phosphorylates membrane proteins, including Ca2+-handling proteins, ion channels, and phospholamban (PLB). Moreover, epinephrine stimulation increases Ca2+ binding to calmodulin (CaM), activatesCa2+-/CaM-dependent kinase type II (CaMKII), inhibits the inward rectifier K+ current (IK1), and enhances the slow-delayed rectifier K+ 2 current (IKs). These actions have led to increases in systolic Ca2+ transient and contraction strength [13].
Parasympathetic influence on cardiomyocytes depends on acetylcholine binding on the cholinergic receptor M2 type2 muscarinic subtype. M2-acetylcholine receptors are G-coupled, and they are formed by inhibitory G protein Gαi linked to the Gβγ subunit. Acetylcholine interaction with the M2receptor causes the dissociation of Gβγ subunits from Gαi with Gβγ activation of the ligand-gated K+ channel IKACh [14]. IKACh activation causes an outward K+ current that results in a decrease in action potential duration (APD). Moreover, heart rate and atrial electrophysiology regulation depends on G protein-coupled inwardly rectifying K+ channels (GIRK) associated with muscarinic and adenosine receptors [15]. GIRKs are located in the sinoatrial node (SAN), atria, atrio-ventricular node (AVN), and Purkinje fibers and lead to membrane hyperpolarization with a subsequent slower firing rate in the SAN. Acetylcholine binding to its muscarinic receptor influences the funny current (If), promoting a more negative action potential and lowering firing rate in the sinoatrial cells. As for intercellular mechanisms, acetylcholine can inhibit gap junction communication leading to contractility velocity reduction through the atrium [16].

2.2. Interplay between Autonomic Nervous System and Cardiomyocytes Action Potential

The autonomic nervous system promotes AF by focal or reentrant mechanisms (Figure 1) [17][18]. Adrenergic activation may promote focal activity by three main principal cellular mechanisms: enhanced automaticity, early afterdepolarization (EAD), or delayed afterdepolarization-associated triggered activity (DAD) [19]. Adrenergic activation causes increased automaticity through the prevention of spontaneous phase 4 depolarization which is promoted by If and inhibited by the IK1 current. Moreover, beta-adrenergic activation may raise focal activity through two principal cellular mechanisms: early afterdepolarization or delayed afterdepolarization-associated triggered activity [20]. Norepinephrine can lead to EAD in a setting of prolonged or shortened action potential duration (APD). β-adrenergic activation through PKA/CaMKII phosphorylation enhances plateau ICa, leading to an increased phase 2 EAD likelihood, especially in individuals suffering from long-QT syndrome, in whom adrenergic augmentation of IKs is deficient [21]. Phase3-EAD is associated with increased Ca2+ transient and shortened APD: it is caused by the simultaneous activation of the sympathetic nervous system with increased Ca2+ and parasympathetic nervous system activation of IKAch. The simultaneous presence of short APD and increased Ca2+ transient leads to late-phase 3 EAD and trigger arrhythmias [8][22][23]. As a matter of fact, APD prolongation permits L-type Ca2+ channels to recover from inactivation, leading to an inward current, causing an EAD.
B-adrenergic stimulation alone can also lead to phase 2 EAD in a setting of prolonged APD by increasing the depolarizing currents (L-type Ca2+ current [ICa, L]) [19]. DAD results from the dysfunction of channel type 2 ryanodine receptor (RyR2) caused by the increased phosphorylation of Ca2+/calmodulin-dependent protein kinase II (CaMKII); it promotes SR Ca2+ release and Na+/Ca2+ exchanger (NCX) activation. All these processes produce a depolarizing transient inward current (Iti) that causes delayed afterdepolarization.
The molecular basis of maintaining reentry mechanisms is not clearly understood; however, in all conceptual models, functional reentry is promoted by atrial refractoriness [24]. Vagal stimulation abbreviates atrial refractoriness by increasing IKACh. In addition, atrial refractoriness abbreviation made by parasympathetic stimulation is characterized by a relevant regional variability that perpetuates the vagal AF-promoting effects. The role of increased refractoriness spatial heterogeneity is confirmed in animal studies in which flecainide terminated the vagus-related pro-arrhythmic effects on AF [25]. A very interesting observation was that, in an ion channel model, a reentry spiral wave induced by a sympathetic stimulation tended to organize and terminate immediately, whereas that induced by a vagal stimulation tended to be maintained in the presence of the refractoriness spatial dispersion. Therefore, this is the explanation as to why an adrenergic AF usually terminates spontaneously, while a vagal AF tends to be maintained [26].
Finally, Figure 2 illustrates a proposed point of view regarding the systemic role of the ANS in Coumel’s triangle. The hypothesis of an “Autonomic Coumel Triangle” stems from the condition of the fundamental role of ANS in all phases of the pathophysiological mechanism of AF. An increase in sympathetic tone favors trigger activity (e.g., ectopic activity from the pulmonary veins, but also from the right atrium) through three known mechanisms: enhanced automatism, EAD, and DAD. Together with sympathetic activation, vagal activity can contribute to triggering activity through the creation of a late-phase 3 EAD. This mechanism is very often present in paroxysmal AF in both healthy and young hearts. However, the role of ANS is also fundamental in forms of persistent AF and/or standing persistent AF where the substrate prevails. In these patients, the role of parasympathetic activity in favoring a spatially heterogeneous action potential and refractory period abbreviation that promotes the occurrence and maintenance of reentrant activity is of crucial importance. At the same time, sympathetic hyperactivity is able to contribute to arrhythmic substrate by promoting increased Ca2+/calmodulin binding and oxidative stress.
Life 13 01139 g002
Figure 2. The Autonomic Coumel’s Triangle. See text for explanation.

References

  1. Coumel, P. Paroxysmal Atrial Fibrillation: A Disorder of Autonomic Tone? Eur. Heart J. 1994, 15 (Suppl. A), 9–16.
  2. Janes, R.D.; Christopher Brandys, J.; Hopkins, D.A.; Johnstone, D.E.; Murphy, D.A.; Armour, J.A. Anatomy of human extrinsic cardiac nerves and ganglia. Am. J. Cardiol. 1986, 57, 299–309.
  3. Armour, J.A.; Murphy, D.A.; Yuan, B.-X.; MacDonald, S.; Hopkins, D.A. Gross, and microscopic anatomy of the human intrinsic cardiac nervous system. Anat. Rec. 1997, 247, 289–298.
  4. Ardell, J.L. The cardiac neuronal hierarchy and susceptibility to arrhythmias. Heart Rhythm. 2011, 8, 590–591.
  5. Pauza, D.H.; Skripka, V.; Pauziene, N.; Stropus, R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat. Rec. 2000, 259, 353–382.
  6. Stavrakis, S.; Nakagawa, H.; Po, S.S.; Scherlag, B.J.; Lazzara, R.; Jackman, W.M. The Role of the Autonomic Ganglia in Atrial Fibrillation. JACC Clin. Electrophysiol. 2015, 1, 1–13.
  7. Po, S.S.; Scherlag, B.J.; Yamanashi, W.S.; Dewards, J.; Zhou, J.; Wu, R.; Geng, N.; Lazzara, R.; Jackman, W.M. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm. 2006, 3, 201–208.
  8. Patterson, E.; Lazzara, R.; Szabo, B.; Liu, H.; Tang, D.; Li, Y.H.; Scherlag, B.J.; Po, S.S. Sodium-Calcium Exchange Initiated by the Ca2+Transient. J. Am. Coll. Cardiol. 2006, 47, 1196–1206.
  9. Armour, J.A. Potential clinical relevance of the ‘little brain’ on the mammalian heart. Exp. Physiol. 2008, 93, 165–176.
  10. Tan, A.Y.; Li, H.; Wachsmann-Hogiu, S.; Chen, L.S.; Chen, P.-S.; Fishbein, M.C. Autonomic Innervation and Segmental Muscular Disconnections at the Human Pulmonary Vein-Atrial Junction. J. Am. Coll. Cardiol. 2006, 48, 132–143.
  11. Francis, G.S. Modulation of peripheral sympathetic nerve transmission. J. Am. Coll. Cardiol. 1988, 12, 250–254.
  12. Lymperopoulos, A.; Rengo, G.; Koch, W.J. Adrenergic Nervous System in Heart Failure. Circ. Res. 2013, 113, 739–753.
  13. Arora, R. Recent Insights into the Role of the Autonomic Nervous System in the Creation of Substrate for Atrial Fibrillation. Circ. Arrhythmia Electrophysiol. 2012, 5, 850–859.
  14. Nerbonne, J.M.; Kass, R.S. Molecular Physiology of Cardiac Repolarization. Physiol. Rev. 2005, 85, 1205–1253.
  15. Heijman, J.; Voigt, N.; Nattel, S.; Dobrev, D. Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression. Circ. Res. 2014, 114, 1483–1499.
  16. Voigt, N.; Heijman, J.; Wang, Q.; Chiang, D.Y.; Li, N.; Karck, M.; Wehrens, X.H.T.; Nattel, S.; Dobrev, D. Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients with Paroxysmal Atrial Fibrillation. Circulation 2014, 129, 145–156.
  17. Sato, R.; Koumi, S. Modulation of the inwardly rectifying K+ channel in isolated human atrial myocytes by? 1-adrenergic stimulation. J. Membr. Biol. 1995, 148, 185–191.
  18. Andrade, J.; Khairy, P.; Dobrev, D.; Nattel, S. The Clinical Profile and Pathophysiology of Atrial Fibrillation. Circ. Res. 2014, 114, 1453–1468.
  19. Chen, P.-S.; Chen, L.S.; Fishbein, M.C.; Lin, S.-F.; Nattel, S. Role of the Autonomic Nervous System in Atrial Fibrillation: Pathophysiology and Therapy. Circ. Res. 2014, 114, 1500–1515.
  20. Qin, M.; Zeng, C.; Liu, X. The cardiac autonomic nervous system: A target for modulation of atrial fibrillation. Clin. Cardiol. 2019, 42, 644–652.
  21. Lemoine, M.D.; Duverger, J.E.; Naud, P.; Qi, Y.Y.; Comtois, P.; Fabritz, L.; Kirchhof, P.; Nattel, S. Arrhythmogenic left atrial cellular electrophysiology in a murine genetic long QT syndrome model. Cardiovasc. Res. 2011, 92, 67–74.
  22. Lu, Z.; Scherlag, B.J.; Lin, J.; Yu, L.; Guo, J.H.; Niu, G.; Jackman, W.M.; Lazzara, R.; Jiang, H.; Po, S.S. Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: Evidence by ablation of ganglionated plexi. Cardiovasc. Res. 2009, 84, 245–252.
  23. Patterson, E.; Jackman, W.M.; Beckman, K.J.; Lazzara, R.; Lockwood, D.; Scherlag, B.J.; Wu, R.; Po, S. Spontaneous Pulmonary Vein Firing in Man: Relationship to Tachycardia-Pause Early Afterdepolarizations and Triggered Arrhythmia in Canine Pulmonary Veins In Vitro. J. Cardiovasc. Electrophysiol. 2007, 18, 1067–1075.
  24. Rebecchi, M.; Panattoni, G.; Edoardo, B.; De Ruvo, E.; Sciarra, L.; Politano, A.; Sgueglia, M.; Ricagni, C.; Verbena, S.; Crescenzi, C.; et al. Atrial fibrillation and autonomic nervous system: A translational approach to guide therapeutic goals. J. Arrhythm. 2021, 37, 320–330.
  25. Lemola, K.; Chartier, D.; Yeh, Y.-H.; Dubuc, M.; Cartier, R.; Armour, A.; Ting, M.; Sakabe, M.; Shiroshita-Takeshita, A.; Comtois, P.; et al. Pulmonary Vein Region Ablation in Experimental Vagal Atrial Fibrillation. Circulation 2008, 117, 470–477.
  26. Ashihara, T.; Yao, T.; Namba, T.; Kawase, A.; Ikeda, T.; Nakazawa, K.; Ito, M. Differences in sympathetic and vagal effects on paroxysmal atrial fibrillation: A simulation study. Biomed. Pharmacother. 2002, 56 (Suppl. 2), 359s–363s.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Cardiac & Cardiovascular Systems
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Marco Rebecchi
,
Francesca Fanisio
,
Fabio Rizzi
,
Alessandro Politano
,
Ermenegildo De Ruvo
,
Cinzia Crescenzi
,
Germana Panattoni
,
Marianna Squeglia
,
Annamaria Martino
,
Stefano Sasso
,
Paolo Golia
,
Giulia Pugliese
,
Sofia Del Gigante
,
Domenico Giamundo
,
Pietro Desimone
,
Domenico Grieco
,
Lucia De Luca
,
Ignazio Giordano
,
Francesco Barillà
,
Marco Alfonso Perrone
,
Leonardo Calò
,
Ferdinando Iellamo
View Times: 553
Entry Collection: Hypertension and Cardiovascular Diseases
Revisions: 2 times (View History)
Update Date: 25 May 2023
Table of Contents
    1000/1000
    Hot Most Recent
    ScholarVision Creations
    Feedback